Work

Targeting the renin–angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

Year: 2005

Type: article

Source: Expert Opinion on Emerging Drugs

DOI: 10.1517/14728214.10.4.729

Authors: Sverre E Kjeldsen, Paulette A Lyle, Andrew M Tershakovec, Richard B Devereux, Suzanne Oparil, Björn Dahlöf, Ulf de Faire, Frej Fyhrquist, Hans Ibsen, Krister Kristianson, Ole Lederballe-Pedersen, Lars H Lindholm, Markku S Nieminen, Per Omvik, Hans Wedel

Institutions: Oslo University Hospital, University of Michigan, Merck & Co., Inc., Rahway, NJ, USA (United States), Cornell University, Weill Cornell Medicine, University of Alabama at Birmingham, Sahlgrenska University Hospital, Karolinska University Hospital, Helsinki University Hospital, Glostrup Hospital, Regionshospitalet Viborg, Umeå University, Haukeland University Hospital, Nordic School of Public Health

Language: English

Topic: Renin-Angiotensin System Studies

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1997187767

FWCI: 1.06

Cites: 107

Cited by: 9

Related to: 10